Mond CB, Peterson MG, Rothfield NFCorrelation of anti-Ro antibody with photosensitivity rash in systemic lupus erythematosus patients. Arthritis Rheum1989 ; 32: 202-204.
18.
Black AK, Fincham N., Greaves MW, Hensby CNTime course changes in levels of arachidonic acid and prostaglandins D2, E2, F2 alpha in human skin following ultraviolet B irradiation. Br J Clin Pharmacol1980; 10: 453—457.
19.
Greaves MW, Sondergaard J.Pharmacologic agents released in ultraviolet inflammation studied by continuous skin perfusion. J Invest Dermatol1970; 54: 365-367.
20.
Hensby CN et al. Time-course of arachidonic acid, prostaglandins E2 and F2 alpha production in human abdominal skin, following irradiation with ultraviolet wavelengths (290-320 nm). Adv Prostaglandin Thromboxane Res1980; 7: 857-860.
21.
Bennion S. et al. The effect of UVB on 6-Keto-PGFla production by cultured human endothelial cells. J Invest Dermatol1984; 82: 428a.
22.
Hawk JL et al. Increased concentrations of arachidonic acid, prostaglandins E2, D2, and 6-oxo-Fl alpha, and histamine in human skin following UVA irradiation . J Invest Dermatol1983; 80: 496-499.
23.
Kupper TS et al. Interleukin 1 gene expression in cultured human keratinocytes is augmented by ultraviolet irradiation. J Clin Invest1987; 80: 430-436.
24.
Granstein RD , Sauder DNWhole-body exposure to ultraviolet radiation results in increased serum interleukin-1 activity in humans. Lymphokine Res1987; 6: 187-193.
25.
Mizutani H. , Black R., Kupper TSHuman keratinocytes produce but do not process pro-interleukin-1 (IL-1) beta. Different strategies of IL-1 production and processing in monocytes and keratinocytes. J Clin Invest1991; 87: 1066-1071.
26.
Bigler CF, Norris DA, Weston WL, Arend WPInterleukin-1 receptor antagonist production by human keratinocytes. J Invest Dermatol1992; 98: 38-44.
Kock A. et al. Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med1990; 172: 1609-1614.
29.
Middleton MH , Norris DACytokin-induced icam-1 expression in human keratinocytes is highly variable in keratinocyte strains from different donors . J Invest Dermatol1995; 104: 489-496.
30.
Kurimoto I. , Streilein JWcis-urocanic acid suppression of contact hypersensitivity induction is mediated via tumor necrosis factor-alpha. J Immunol1992 ; 148: 3072-3078.
31.
Vinek V.Sunlight induced progression of aids. [review]. Med Hypotheses1995; 44: 119-123.
32.
Walsh LJUltraviolet b irradiation of skin induces mast cell degranulation and release of tumour necrosis factor-alpha. Immunol Cell Biol1995; 73: 226-233.
33.
Amse; K. et al. Cytokine m odulation of keratinocyte cytokines. J Invest Dermatol1990; 94: 101S-107S.
34.
Kupper TSMechanisms of cutaneous inflammation. Arch Dermatol1989; 125: 1406-1412.
35.
Chouaib S., Branellec D., Buurman WAMore insights into the complex physiology of TNF. Immunol Today1991; 12: 141-142.
36.
Jacob COStudies on the role of tumor necrosis factor in murine and human autoimmunity . J Autoimmun1992; 5: 133-143.
37.
Kirnbauer R. et al. IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by hjuman epidermal cells and epidermoid carcinoma cell lines. J Immunol1989; 142: 1922-1928.
38.
Urbanski A. et al. Ultraviolet light induces increased circulating interleukin-6 in humans. J Invest Dermatol1990; 94: 808-811.
39.
Turksen K. et al. Interleukin 6: insights to its function in skin by overexpression in transgenic mice. Proc Natl Acad Sci (USA)1992; 89: 5068-5072.
40.
Aberer W. et al. Ultraviolet light depletes surface markers of Langerhans cells . J Invest Dermatol1981; 76: 202-210.
41.
Yoshikawa T. , Kurimoto I., Streilein JWTumour necrosis factor-alpha mediates ultraviolet light B-enhanced expression of contact hypersensitivity. Immunol1992; 76: 264-271.
42.
Beissert S. , Ullrich SE, Hosoi J., Granstein RDSupernants from uvb radiation-exposed keratinocytes inhibit langerhans cell presentation of tumor-associated antigens via il-10 content. J Leuk Biol1995; 58: 234-240.
43.
Ullrich SEMechanism involved in the systemic suppression of antigen-presenting cell function by uv irradiation. Keratinocyte-derived IL-10 modulates antigen-presenting cell function of splenic adherent cells. J Immunol1994 ; 152: 3410-3416.
44.
Krutmann K.Grewe Involvement of cytokines, dna damage, and reactive oxygen intermediates in ultraviolet radiation-induced modulation of intercellular adhesion molecule-1 expression/ [review]. J Invest Dermatol1995; 105: 67S-70S.
45.
Grewe K., Gyufko K., Krutmann J.Interleukin-10 production by cultured human keratinocytes: regulation by ultraviolet b and ultraviolet al radiation. J Invest Dermatol1995; 104: 3-6.
46.
el-Ghorr AA , Norval M.A monoclonal antibody to cis-urocanic acid prevents the ultraviolet-induced changes in langerhans cells and delayed hypersensitivity responses in mice, although not preventing dendritic cell accumulation in lymph nodes draining the site of irradiation and contact hypersensitivity responses. J Invest Dermatol1995; 105: 264-268.
47.
Muller G. et al. IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo. J Immunol1995; 155: 4661-4668.
48.
Davis TL, Lyde CB, Davis BM, Sontheimer RDPerturbation of experimental ultraviolet light-induced erythema by passive transfer of serum from subacute cutaneous lupus erythematosus patients. J Invest Dermatol1989; 92: 573-577.
49.
Norris DACytokine modulation of adhesion molecules in the regulation of immunologic cytotoxicity of epidermal targets. J Invest Dermatol1990; 95: 111S-120S.
50.
Norris DAImmune Mechanisms in Cutaneous Disease. Marcel Dekker, Inc; New York, NY, 1989 pp 123-166.
51.
Dustin ML, Singer KH, Tuck DT, Springer TAAdhesion of T lymphoblasts to epidermal keratinocytes is regulated by interferon-gamma and is mediated by intercellular adhesion molecule-1 (ICAM-1). JExp Med1988; 167: 1323-1340.
52.
Makgoba MW et al. Functional evidence that intercellular adhesion molecule 1 (ICAM-1) is a ligand for LFA-1 dependent adhesion in T cell-mediated cytotoxicity. Eur J Immunol1988; 18: 637-640.
53.
Makgoba MW et al. ICAM-1 a ligand for LFA-1 dependent adhesion by B, T and myeloid cells. Nature1988; 331: 86-91.
54.
Dustin ML et al. A natural adherence molecule (ICAM-1): Induction by IL-1 and interferon gamma, tissue distribution, and function. J Immunol1986; 137: 245-254.
55.
Kashihara Sawami M., Norris DAThe state of differentiation of cultured human keratinocytes determines the level of intercellular adhesion molecule-1 (ICAM-1) expression induced by gamma interferon. J Invest Dermatol1992 ; 98: 741-747.
56.
Norris DA et al. Ultraviolet radiation can either suppress or induce expression of intercellular adhesion molecule 1 (ICAM-1) on the surface of cultured human keratinocytes. J Invest Dermatol1990; 95: 132-138.
57.
Bennion SD et al. In three types of interface dermatitis, different patterns of expression of intercellular adhesion molecule-1 (icam-1) indicate different triggers of disease. J Invest Dermatol1995 ; 105: 71S-79S.
58.
Barker Jnwn et al. Marked synergism between tumor necrosis factor alpha and interferon-gamma in regulation of keratinocyte-derived chemotactic factors and adhesion molecules. J Clin Invest1990; 95: 605-608.
59.
Stephansson E., Ros AMExpression of intercellular adhesion molecule-1 (icam-1) and okm5 in uva- and uvb-induced lesions in patients with lupus erythematosus and polymorphous light eruption. Arch Dermatol Res1993; 285: 328-333.
60.
Springer TATraffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell1994; 76: 301-314.
61.
Simon SI et al. L-selectin (cd621) cross-linking signals neutrophil adhesive functions via the MAC-1 (CDl lb/CD18) beta 2-integrin. J Immunol1995; 155: 1502-1514.
62.
Huang AJ et al. Endothelial cell cytosolic free calcium regulates neutrophil migration across monolayers of endothelial cells. J Cell Biol1993; 120: 1371-1380.
63.
Beynon HL et al. Combinations of low concentrations of cytokines and acute agonists synergize in increasing the permeability of endothelial monolayers. Clin Exp Immunol1993; 91: 314-319.
64.
Cornelius LA et al. Selective upregulation of intercellular adhesion molecule (ICAM-1) by ultraviolet b in human dermal microvascular endothelial cells. J Invest Dermatol1994 ; 103: 23-28.
65.
Norris P. et al. The expression of endothelial leukocyte adhesion molecule-1 (ELAM-1), intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in experimental cutaneous inflammation: a comparison of ultraviolet B erythema and delayed hypersensitivity. J Invest Dermatol1991; 96: 763-770.
66.
Sauder DN, Wong D., Laskin C.Epidermal cytokines in murine lupus. J Invest Dermatol1993; 100: 42S-.46S.
67.
Velthuis PJ , van Weelden H., vanWichen D., BaartdelaFaille H.Immunohistopathology of light-induced skin lesions in lupus erythematosus. Acta Derm Venereol (Stockholm) 1990; 70: 93-98.
Vole Platzer et al. Accumulation of gamma delta T cells in chronic cutaneous lupus erythematosus. J Invest Dermatol1993 ; 100: 84S-91S.
70.
Kaufmann She.Heat shock proteins and the immune response . Immunol Today1990; 11: 129-136.
71.
Norton PM, Isenberg DA, Latchman DSElevated levels of the 90 kd heat shock protein in a proportion of SLE patients with active disease. J Autoimmun1989; 2: 187-195.
Sontheimer et al. Serologic and HLA associations in subacute cutaneous lupus erythematosus: a clinical subset of lupus erythematosus. Ann Int Med1982; 97: 664-671.
74.
Weston WL, Harmon C., Peebles C.A serologic marker for neonatal lupus. Brit J Dermatol1982; 107: 377-382.
75.
Sontheimer RDQuestions pertaining to the true frequencies with which anti-Ro/SS-A autoantibody and the HLA-DR3 phenotype occur in subacute cutaneous lupus erythematosus patients. J Am Acad Dermatol1987 ; 16: 130-134.
76.
Lee LA, David KMCutaneous lupus erythematosus. Curr ProblDermatol1989 ; 1: 161-210.
77.
Buyon JP et al. Acquired congenital heart block. Pattern of maternal antibody response to biochemically defined antigens of the SSA/Ro-SSB/La system in neonatal lupus. J Clin Invest1989; 84: 627-634.
78.
McCauliffe DP, Sontheimer RDMolecular characterization of the Ro/SS-A autoantigens. J Invest Dermatol1993; 100: 73S-79S.
79.
Lee LA et al. Autoantibody Markers of Cutaneous Lupus Erythematosus. J Invest Derinatol1993; 100: 573.
80.
Provost TT, Herrera-Esparaza R., Diaz LANucleoprotein autoantibodies in lupus erythematosus. J Invest Dermatol1985; 85: 133S-139S.
81.
David Bajar KM et al. Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus. J Invest Dermatol1992; 99: 251-257.
82.
Fabre VC et al. Twenty percent of biopsy specimens from sun-exposed skin of normal young adults demonstrate positive immunofluorescence [see comments] . Arch Dermatol1991; 127: 1006-1011.
83.
Leibold AM, Bennion S., David-Bajar K., Schleve MJOccurrence of positive immunofluorescence in the dermo-epidermal junction of sun-exposed skin of normal adults. J Cutan Pathol1994; 21: 200-206.
Ansel JC et al. Effects of UV radiation on autoimmune strains of mice: increased mortality and accelerated autoimmunity in BXSB male mice. J Invest Dermatol1985; 85: 181-186.
86.
Natali PG, Tan EMExperimental skin lesions in mice resembling systemic lupus erythematosus . Arthritis Rheum1973; 16: 579-589.
87.
LeFeber WP et al. Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured human keratinocytes. J Clin Invest1984; 74: 1545-1551.
88.
Furukawa et al. Binding of antibodies to the extractable nuclear antigens SS- A/RO and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the photogenesis of photosensitive cutaneous lupus. 1990; 94: 77-85.
89.
Jones SKThe effects of hormonal and other stimuli on cell-surface Ro/SSA antigen expression by human keratinocytes in vitro: their possible role in the induction of cutaneous lupus lesions. Br J Dermatol1992; 126: 554-560.
90.
Jones SKUltraviolet radiation (UVR) induces cell-surface Ro/SSA antigen expression by human keratinocytes in vitro: a possible mechanism for the UVR induction of cutaneous lupus lesions. Br J Dermatol1992; 126: 546-553.
91.
Casciola-Rosen LA, Anhalt G., Rosen A.Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes [see comments]. J Exp Med1994; 179: 1317-1330.
92.
Tan EMAutoimmunity and apoptosis [comment]. J Exp Med1994; 179: 1083-1086.
93.
Golan TD, Elkon KB, Gharavi AE, Krueger JGEnhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythemtosus patients after ultravioletB/ultraviolet A radiation. J Clin Invest1992; 90: 1067-1076.
94.
Furukawa F. et al. Estradiol enhances binding to cultured human keratinocytes of antibodies specific for SS-A/RO and SS/B/La. Another possible mechanism for estradiol influence of lupus erythematosus. J Immunol1988; 141: 1480-1488.
95.
Lee LA et al. Pattern of cutaneous immunoglobulin G deposition in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti-Ro (SSA) autoantibodies into human skin-grafted mice. J Clin Invest1989; 83: 1556-1562.
96.
Nieboer C., Tak Diamand Z, VanLeeuwen Wallau HE. Dust-like particles: a specific direct immunofluorescence pattern in sub-acute cutaneous lupus erythematosus. Br J Dermatol1988; 118: 725-729.
97.
Golan TD, Gharavi AE, Elkon KBPenetration of autoantibodies into living epithelial cells. J Invest Dermatol1993; 100: 316-322.
98.
Norris DA et al. The role of RNP, Sm, and SS-A/Ro-specific antisera from patients with lupus erythematosus in inducing antibody-dependent cellular cytotoxicity (ADCC) of targets coated with nonhistone nuclear antigens. Clin Immunol Immunopathol1984; 31: 311320.
99.
Bennion SD et al. IgG subclasses in the serum and skin in subacute cutaneous lupus erythematosus and neonatal lupus erythematosus. J Invest Dermatol1990; 95: 643-646.
100.
Norris DA et al. Systematic comparison of antibody-mediated mechanisms of keratinocyte lysis MIT ∈. J Immunol1985; 135: 1073-1079.
101.
Furukawa F. , Kanauchi H., Imamura S.Susceptibility to uvb light in cultured keratinocytes of cutaneous lupus erythematosus. Dermatology1994; 189 (Suppl. 1): 18-23.
102.
Norris DA, Lee LAAntibody-dependent cellular cytotoxicity and skin disease. J Invest Dermatol1985 ; 85: 165S-175S.
Fadok VA et al. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol1992; 148: 2207-2216.
106.
Norris DAEditorial: Differential control of cell death in the skin. Arch Dermatol1995 ; 131: 945-948.
107.
Wright SC et al. Apoptosis and DNA fragmentation precede TNF-induced cytolysis in U937 cells. J Cell Biochem1992; 48: 344-355.
108.
Lowin B., Beermann F., Schmidt A., Tschopp J.A null mutation in the perforin gene impairs cytolytic t lymphocyte- and natural killer cell-mediated cytotoxicity. Proc Natl Acad Sci (USA)1994; 91: 11571-11575.
109.
Lowin B., Hahne M., Mattmann C., Tschopp J.Cytolytic t-cell cytotoxicity is mediated through perforin and fas lytic pathways . Nature1994; 370: 650-652.
110.
Irmler M. et al. Granzyme a is an interleukin 1 beta-converting enzyme. J Exp Med1995; 181: 1917-1922.
111.
Stalder T., Hahn S., Erb P.Fas antigen is the major target molecule for CD4 + T cell-mediated cytotoxicity . J Immunol1994; 152: 1127-1133.
112.
Suda T., Takahashi T., Golstein P., Nagata S.Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell1993; 75: 1169-1178.
113.
Budtz PE, Spies I.Epidermal tissue homeostasis: apoptosis and cell emigration as mechanisms of controlled cell deletion in the epidermis of the toad, Bufo bufo. Cell Tissue Res1989; 256: 475-486.
114.
Weedon D., Strutton G.Apoptosis as the mechanism of the involution of hair follicles in catagen transformation. Acta Derm Venereol (Stockholm ) 1981; 61: 335-3399.
115.
McCall CA, Cohen JJProgrmamed cell death in terminally differentiating keratinocytes: role of endogenous endonuclease. J Invest Dermatol1991; 97: 111-114.
116.
Weedon D.Apoptosis in lichen planus. Clin Exp Dermatol1980; 5: 425-430.